Effectiveness and safety of weekly paclitaxel and cetuximab as a salvage chemotherapy following immune checkpoint inhibitors for recurrent or metastatic head and neck squamous cell carcinoma: A multicenter clinical study.
Takahiro WakasakiTomomi ManakoRyuji YasumatsuHirotaka HaraSatoshi TohMuneyuki MasudaMoriyasu YamauchiYuichiro KuratomiEmi NishimuraToranoshin TakeuchiMioko MatsuoRina JiromaruKazuki HashimotoNoritaka KomuneTakashi NakagawaPublished in: PloS one (2022)
Although PC following ICIs shows dramatic efficacy, careful monitoring of AEs, including DI-IP, is recommended.